Business Services Industry

Gilead Announces Dismissal of Securities Litigation

Business Wire, May 16, 2006

FOSTER CITY, Calif. -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that on May 12, 2006, Judge Martin J. Jenkins of the United States District Court for the Northern District of California dismissed with prejudice the securities class action complaint filed in 2003 against Gilead and certain of its current and former officers, In re Gilead Sciences Securities Litigation, Case No. C03-4999 MJJ. The complaint had alleged that the defendants violated federal securities laws by making allegedly false and misleading statements in 2003. The plaintiffs have not indicated whether they will appeal the dismissal.

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

For more information on Gilead Sciences, please visit www.gilead.com or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

COPYRIGHT 2006 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with Thompson Gale